scispace - formally typeset
H

Herbert Kim Lyerly

Researcher at Duke University

Publications -  138
Citations -  7923

Herbert Kim Lyerly is an academic researcher from Duke University. The author has contributed to research in topics: Immunotherapy & Cancer. The author has an hindex of 40, co-authored 138 publications receiving 7444 citations. Previous affiliations of Herbert Kim Lyerly include Howard Hughes Medical Institute & Peking University.

Papers
More filters
Journal ArticleDOI

Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1

TL;DR: A 20-amino acid sequence from the macrophage-tropic BaL isolate of HIV-1 was sufficient to confermacrophage tropism on HTLV-IIIB, a T cell line--tropic isolate, and this small sequence element is in the V3 loop, the envelope domain that is the principal neutralizing determinant of HIV -1.
Journal ArticleDOI

Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA.

TL;DR: Dendritic cells generated from the peripheral blood mononuclear cells of healthy individuals or from cancer patients transfected with carcinoembryonic antigen (CEA) mRNA stimulate a potent CD8+ cytotoxic T lymphocyte response in vitro, providing a general method for inducing, as well as measuring, CEA-specific CTL responses across a broad spectrum of HLA haplotypes.
Journal Article

Induction of Tumor Immunity and Cytotoxic T Lymphocyte Responses Using Dendritic Cells Transfected with Messenger RNA Amplified from Tumor Cells

TL;DR: It is demonstrated that tumor mRNA, isolated from murine tumor cell lines or from primary human tumor cells microdissected from frozen tissue sections, can be amplified without loss of function and provided the foundations for an effective and broadly applicable treatment that does not require the characterization of the relevant antigenic profile in each patient and will not be limited by tumor tissue availability for antigen preparation.
Journal Article

Migration of Human Dendritic Cells after Injection in Patients with Metastatic Malignancies

TL;DR: It is demonstrated that DC distribution to sites of lymphoid tissue is dramatically affected by the mode of administration, and a small percentage of DCs injected intradermally migrated rapidly to the regional lymphatics in some individuals.
Journal ArticleDOI

Immunotherapy of cancer with dendritic-cell-based vaccines

TL;DR: Immunotherapy using autologous DC loaded with unfractionated tumor-derived antigens in the form of RNA emerges as a potentially powerful and broadly useful vaccination strategy for cancer patients.